Dr. Klempner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
119 Belmont St
Department Of Infectious Disease
Worcester, MA 01605Phone+1 508-856-1720Fax+1 508-856-5981
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 1973 - 1975
- Weill Cornell MedicineClass of 1973
Certifications & Licensure
- MA State Medical License 1974 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1986
Publications & Presentations
PubMed
- A Phase 1 Study in Healthy Subjects to Evaluate the Safety and Pharmacokinetics of a Human Monoclonal Antibody (S315) Against Diphtheria Toxin.John Z Sullivan-Bólyai, Larry B Allen, Rebecca Cannon, Kenya P Cohane, Elise Dunzo
The Journal of Infectious Diseases. 2024-11-21 - 6 citationsMucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants.Qi Li, Fiachra Humphries, Roxie C Girardin, Aaron Wallace, Monir Ejemel
Frontiers in Immunology. 2022-01-01 - 10 citationsBlocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibodyZachary A. Schiller, Michael J. Rudolph, Jacqueline R. Toomey, Monir Ejemel, Alan LaRochelle
The Journal of Clinical Investigation. 2021-06-01
Journal Articles
- Oxford University Press Has Registered This DOI Pre-PublicationLinden Hu, Mark S Klempner, Oxford University Press
Press Mentions
- 12 Diseases and Health Conditions Local Biotech Companies Are Tackling Right NowFebruary 21st, 2023
- A Lyme Vaccine — or Something Similar — Is on the HorizonAugust 17th, 2022
- The Lyme Vaccine That Got AwaySeptember 16th, 2021
- Join now to see all
Grant Support
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2006–2011
- National Emerging Infectious Diseases Laboratories OperationsNational Institute Of Allergy And Infectious Diseases2006–2010
- Environmental Health And Safety CoreNational Institute Of Allergy And Infectious Diseases2006–2010
- National Center/Emerging Infectous Diseases &BiodefenseNational Institute Of Allergy And Infectious Diseases2003–2006
- Lyme Disease: Spirochete Invasion And Host ImmunityNational Institute Of Allergy And Infectious Diseases2001–2005
- New Method For Detecting Bacillus Anthracis SporesNational Institute Of Allergy And Infectious Diseases2002–2003
- Ceftriaxone And Doxycycline In Patients With Seronegative Chronic Lyme DiseaseNational Center For Research Resources1998–2002
- Ceftriaxone &Doxycycline In Patients With Seropositive Chronic Post Lyme DiseaseNational Center For Research Resources1998–2002
- Clinical Studies Of Chronic Lyme DiseaseNational Institute Of Allergy And Infectious Diseases1996–2000
- Lyme Disease--Spirochete Invasion And Host ImmunityNational Institute Of Allergy And Infectious Diseases1994–1998
- Pathogenesis Of Lyme BorreliosisNational Institute Of Allergy And Infectious Diseases1993–1996
- Diagnosis Of Early Lyme DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1991–1994
- Biology Of The Human Neutrophil Plasma MembraneNational Institute Of Allergy And Infectious Diseases1987–1991
- Mechanism Of Action Of Tetanus ToxinNational Institute Of Allergy And Infectious Diseases1987
- Biology Of The Human Neutrophil Plasma MembraneNational Institute Of Allergy And Infectious Diseases1985–1987
- Mechanism Of Action Of Tetanus ToxinNational Institute Of Allergy And Infectious Diseases1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: